SCR-LIP-000191 · Claim · machine-readable JSON →
Bioimpedance spectroscopy of regional tissue fluid distinguished lipedema from Dercum's disease (lower leg/arm R0 ratio in lipedema, p<0.001) and detected stage 1 lipedema versus matched controls (leg/arm ratio R0 p=0.01, R1 p=0.007), with leg extracellular water increasing across lipedema stages (p=0.03), proposing BIS as an objective adjunct biomarker for diagnosis and staging.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 3 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Lipedema and Dercum's Disease: A New Application of Bioimpedance — Crescenzi et al. (2019) ✓ verified — refining · cross sectional · 2019 · reading confidence: high
The question concerns clinical criteria and stage/type classification systems and their reliability. This study uses the conventional clinical stage classification (stage 1-3) as a reference and proposes an objective bioimpedance biomarker [grade capped moderate->low per curated Oxford N4]
Context (PECO)
Answers these questions
- Is lipedema underdiagnosed, and can screening tools help identify it? consistent
- What clinical criteria and stage/type classification systems are used to diagnose and grade lipedema, and how reliable are they? refining
- Can screening tools or questionnaires help identify lipedema cases? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-06-02 — merged · absorbed duplicate SCR-LIP-000286
- 2026-05-31 — created · auto-ingested for SQ-LIP-000022